Agree with you tschussmann, that there will be some sales but not much without reimbursement being available. What I hope Anavex pulls out of their hat after approval (assuming it happens) is a tier 1 partnership with a monster company who will plow the road for blarcasemine sales.
Market Data 
Markets 
